Live Breaking News & Updates on Golden Biotechnology Corp

Stay updated with breaking news from Golden biotechnology corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ASCO GI 2024: Golden Biotech's Antroquinonol Shows Significantly Prolonged Survival in Untreated Metastatic Pancreatic Cancer Patients

ASCO GI 2024: Golden Biotech's Antroquinonol Shows Significantly Prolonged Survival in Untreated Metastatic Pancreatic Cancer Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

South Korea , United States , T Ai Pei , Prnewswire Golden Biotechnology Corp , Golden Biotechnology Corporation The Company , American Society Of Clinical Oncology , Golden Biotechnology Corp , Biotechnology Corp , Pancreatic Cancer , Cancers Symposium , Golden Biotech , Trial Registration Number , American Society , Clinical Oncology , Clinically Meaningful Goals , For Pancreatic Cancer , Orphan Drug Designation , Acute Myeloid Leukemia , Hepatocellular Carcinoma , Golden Biotechnology Corporation ,

100% Recovery-GoldenBiotech Announces Topline Results from Unblinded COVID-19 Trial for Oral New Drug Antroquinonol in Hospitalized Mild, Moderate and Severe Patients

/PRNewswire/ Golden Biotechnology Corp.(TPEx:4132) ("GoldenBiotech", GBC), a leading Taiwanese biopharmaceutical company, announces that its Phase 2. ....

T Ai Pei , United States , Golden Biotechnology Corporation , Golden Biotechnology Corp , Prnewswire Golden Biotechnology Corp Tpex , Biotechnology Corp , Outcome Measure , Outcome Measures , Improvement Ordinal , Golden Biotechnology , Biotechnology Corporation , Golden Biotechnology Corp ,

100% Recovery-GoldenBiotech Announces Topline Results from Unblinded COVID-19 Trial for Oral New Drug Antroquinonol in Hospitalized Mild, Moderate and Severe Patients

/PRNewswire/ Golden Biotechnology Corp.(TPEx:4132) ("GoldenBiotech", GBC), a leading Taiwanese biopharmaceutical company, announces that its Phase 2. ....

T Ai Pei , United States , Golden Biotechnology Corporation , Golden Biotechnology Corp , Prnewswire Golden Biotechnology Corp Tpex , Biotechnology Corp , Outcome Measure , Outcome Measures , Improvement Ordinal , Golden Biotechnology , Biotechnology Corporation , Golden Biotechnology Corp , Biotechnology , Health Care Amp Hospitals , Medical Pharmaceuticals , Clinical Trials Amp Medical Discoveries ,

GBC seeks US authorization for oral COVID-19 drug

Golden Biotechnology Corp (GBC, 國鼎) plans to apply for emergency use authorization in the US for its experimental COVID-19 drug after positive results in its phase 2 clinical trials, the company said.
GBC on Wednesday announced some of the results from randomized, double-blind and placebo-controlled studies in phase 2 clinical trials of its COVID-19 oral drug antroquinonol, dubbed Hocena, for the treatment of people hospitalized with mild-to-moderate COVID-19 symptoms.
In the trials, 97.9 percent of people recovered by the 14th day after being given the drug and all participants recovered by the 28th day, GBC spokesman Alan Tseng (曾木增) said yesterday.
“Recovered” meant ....

T Ai Pei , Liu Sheng Yung , Chen Yung Chi , Alan Tseng , Senhwa Biosciences Inc , Labcorp Drug Development , Taipei Exchange On , Taipei Exchange , Golden Biotechnology Corp , Taipei Times , Kao Shih Ching , Biotechnology Corp , Emerging Stock Board , The Taipei Times ,

Taiwan company's share price soars on good news for oral COVID drug | Taiwan News

Golden Biotechnology's Antroquinonol passes Phase II clinical trial with flying colors.Golden Biotechnology's Antroquinonol passes phase II clinical trial | 2022-01-06 19:22:00 ....

T Ai Pei , United States , South Korea , Alex Liu , Sanova Pharma , Korea Co , Drug Administration , Taiwan News , National Library Of Medicine , Taipei Exchange , Golden Biotechnology Corp , Golden Biotechnology , United States Food , Biotechnology President Alex Liu , National Library ,